Dr. Enrique Polanco, MD
What this data tells you about Dr. Polanco
Dr. Enrique Polanco is a cardiovascular disease in Melbourne, FL, with 19 years in practice. Based on federal Medicare data, Dr. Polanco performed 27,327 Medicare services across 4,396 unique beneficiaries.
Between the years covered by Open Payments, Dr. Polanco received a total of $10,287 from 35 pharmaceutical and/or device companies across 236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Polanco is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Inclisiran injection (Leqvio) for cholesterol | 16,472 | $9 | $24 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 3,413 | $0 | $2 |
| Electrocardiogram (EKG), 12-lead | 1,368 | $10 | $33 |
| Contrast dye for imaging (iodine-based) | 1,300 | $0 | $1 |
| Office visit, established patient (30-39 min) | 1,097 | $90 | $255 |
| EKG interpretation and report | 320 | $6 | $18 |
| Hospital follow-up visit, high complexity | 307 | $93 | $232 |
| Echocardiogram, transthoracic | 272 | $139 | $385 |
| Office visit, established patient (20-29 min) | 230 | $64 | $180 |
| Remote pacemaker/defibrillator monitoring, 90 days | 208 | $15 | $46 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 205 | $24 | $87 |
| Hospital follow-up visit, moderate complexity | 194 | $60 | $159 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 189 | $18 | $53 |
| Initial hospital admission, high complexity | 183 | $127 | $362 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 175 | $87 | $228 |
| Remote pacemaker monitoring, 90 days | 145 | $21 | $60 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 112 | $13 | $54 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 106 | $10 | $28 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 86 | $324 | $854 |
| Ultrasound of heart with probe in esophagus, with report | 86 | $81 | $212 |
| Programming of dual lead pacemaker system | 85 | $54 | $158 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 78 | $47 | $139 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 66 | $19 | $52 |
| Initial hospital admission, moderate complexity | 62 | $102 | $264 |
| Drug injection, under skin or into muscle | 60 | $10 | $42 |
| New patient office visit (45-59 min) | 59 | $107 | $335 |
| Ultrasound of heart, follow-up | 58 | $19 | $50 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 52 | $2 | $7 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 49 | $18 | $52 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 49 | $25 | $117 |
| Ultrasound of heart blood flow, valves and chambers | 39 | $14 | $36 |
| External shock to heart to regulate heart beat | 32 | $77 | $218 |
| Evaluation of implantable heart and blood vessel monitoring system | 32 | $35 | $107 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 22 | $67 | $172 |
| Programming of single lead pacemaker system | 21 | $42 | $132 |
| Ct scan of blood vessels and grafts of heart with contrast | 16 | $223 | $569 |
| Cardiac catheterization | 15 | $196 | $607 |
| Office visit, established patient (10-19 min) | 15 | $35 | $113 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 14 | $30 | $90 |
| Ultrasound of heart | 12 | $31 | $88 |
| Office visit, established patient, complex (40-54 min) | 12 | $140 | $357 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 11 | $177 | $454 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (63%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Polanco is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), and speaking/promotional industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Polanco experienced with inclisiran injection (leqvio) for cholesterol?
Does Dr. Polanco receive payments from pharmaceutical companies?
How do Dr. Polanco's costs compare to other cardiovascular diseases in Melbourne?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology